MHLW Japan Approves Plan For Vision Improvement Using iPS Cells
This article was originally published in PharmAsia News
A Ministry of Health, Labor and Welfare investigational committee approved the content of a plan for clinical research regarding the use of iPS cells to regenerate part of the retina in patients with lost vision.
You may also be interested in...
In a bold move to expand into cancer treatment markets, Siemens Healthineers has agreed to a $16.4bn all-cash deal to acquire radiation therapy leader Varian.
Concern and skepticism about Russia's rapid vaccine roll-out. Meanwhile Japan is latest to reach reaches deal with Pfizer/BioNTech.
Sun’s Q1 earnings were dented by provisions related to the generic pricing investigation settlement with the US Department of Justice of arm Taro, and the impact of pandemic-related lockdowns. Some clinic-administered products bore the brunt of lock-downs in parts of the US, though market share was unaffected.